The limited intestinal absorption via paracellular pathway is responsible for the low oral bioavailability of doxorubicin-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The limited intestinal absorption via paracellular pathway is responsible for the low oral bioavailability of doxorubicin

Published:2012-12-19 Issue:7 Volume:43 Page:579-591
ISSN:0049-8254
Container-title:Xenobiotica
language:en
Short-container-title:Xenobiotica

Author:

Kim Ji-Eon,Cho Hyun-Jong,Kim Jung Sun,Shim Chang-Koo,Chung Suk-Jae,Oak Min-Ho,Yoon In-Soo,Kim Dae-Duk

Publisher

Informa UK Limited

Subject

Health, Toxicology and Mutagenesis,Pharmacology,Toxicology,Biochemistry,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/00498254.2012.751140

Reference54 articles.

1. Quantitative Approaches To Delineate Paracellular Diffusion in Cultured Epithelial Cell Monolayers

2. Unidirectional fluxes of rhodamine 123 in multidrug-resistant cells: evidence against direct drug extrusion from the plasma membrane.

3. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells

4. Intestinal Permeation Enhancers

5. Effect of P-glycoprotein inhibitor, verapamil, on oral bioavailability and pharmacokinetics of irinotecan in rats

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization and in vitro evaluation of melanin nanoparticles as an oral drug delivery system: Studies using Caco-2 cell model and molecular dynamics simulations;Journal of Drug Delivery Science and Technology;2024-09

2. Quantum computational, molecular structure, experimental spectra, and molecular docking studies on (S)-3-benzyl-5-(phenylselanyl)-6-(p-tolyl)-3,4-dihydropyran-2-one;Chemical Physics Impact;2024-06

3. Effect of Tight Junction-Modulating FCIGRL-Modified Peptides on the Intestinal Absorption of Doxorubicin in Rats;Pharmaceutics;2024-05-11

4. Preparation of self-assembly silica redox nanoparticles to improve drug encapsulation and suppress the adverse effect of doxorubicin;ADMET and DMPK;2023-07-04

5. Recent Advances in Doxorubicin Formulation to Enhance Pharmacokinetics and Tumor Targeting;Pharmaceuticals;2023-05-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3